![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023 PR Newswire TEL AVIV, Israel, April 4, 2024 TEL AVIV, Israel, April 4, 2024 /PRNewswire/...
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis PR Newswire TEL AVIV, Israel, March 15...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0034 | 1.13712374582 | 0.299 | 0.32 | 0.2773 | 56882 | 0.29837865 | CS |
4 | -0.0468 | -13.4020618557 | 0.3492 | 0.3792 | 0.2616 | 60576 | 0.30374315 | CS |
12 | -0.063 | -17.2413793103 | 0.3654 | 0.4395 | 0.2616 | 56855 | 0.35666716 | CS |
26 | -0.1477 | -32.8149300156 | 0.4501 | 0.4688 | 0.2616 | 137876 | 0.355487 | CS |
52 | -2.2176 | -88 | 2.52 | 5.47 | 0.26 | 191006 | 0.91001711 | CS |
156 | -43.4976 | -99.3095890411 | 43.8 | 51.3 | 0.26 | 153543 | 12.50327856 | CS |
260 | -100.7976 | -99.7008902077 | 101.1 | 110.7 | 0.26 | 154941 | 33.27717083 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions